EYLEA^™ (aflibercept) Injection and ARCALYST^® (rilonacept) exemplify Regeneron's commitment to discover, invent, develop, manufacture, and commercialize important medicines for patients suffering from serious diseases.

More information on EYLEA
Full U.S. Prescribing Information for EYLEA

More information on ARCALYST
Full U.S. Prescribing Information for ARCALYST

The product information in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.